Cannabis and Hemp Market Size By Types (Flowers, Concentrates, Others), By Applications Covered (Medicinal, Recreational, Industrial, Others) and Regional Forecast to 2033

Cannabis and Hemp Market Size

The Global Cannabis and Hemp Market was valued at approximately USD 30.35 billion in 2024 and is projected to rise to around USD 38.41 billion in 2025, ultimately reaching a staggering USD 252.72 billion by 2033, showcasing an impressive compound annual growth rate (CAGR) of 26.55% over the forecast period from 2025 to 2033.

The U.S. Cannabis and Hemp Market accounted for roughly USD 17.8 billion in 2024, making it a dominant force globally, fueled by progressive legalization, growing consumer demand for medical and recreational cannabis, and expanding use of hemp-based products in wellness, food, and industrial applications.

Key Findings

• Market Size – Valued at USD 38.41 billion in 2025, expected to reach USD 252.72 billion by 2033.

• Growth Drivers – Percentage‑based growth driven by legalisation rate increases, hemp beverage adoption, fibre usage improvements and extraction tech efficiencies.

• Trends – Uptake of hemp‑derived beverages increased by over X %, hemp fibre applications account for over 25 % of supply usage, CBD beverage segment grew over 50 %.

• Key Players – Folium Biosciences | Canopy Growth Corporation | Curaleaf Holdings | Ecofibre Limited | Harvest Health and Recreation

• Regional Insights – North America holds approximately X % market share, Europe holds around X %, Asia‑Pacific holds around X %, Middle East & Africa remaining share under X %, detailing industrial and recreational splits.

• Challenges – Percentage‑based impacts from regulatory fragmentation, compliance cost burdens, banking restrictions and supply volatility exceeding X %.

• Industry Impact – Percent influence on job creation, economic value add, shift from alcohol shelf share, sustainable material penetration exceeding X %.

• Recent Developments – Manufacturers’ innovations contributed to percentage increases in beverage format adoption, licencing uptick, and AI‐cultivation adoption over X %.

The global Cannabis and Hemp market is distinguished by its dual structure: Cannabis products targeting medical and recreational users, and Hemp products serving industrial segments such as textiles, construction, food, and bioplastics. Cannabis and Hemp cultivation spans North America, Europe, Asia‑Pacific and emerging markets. For instance, industrial hemp revenue in 2024 reached around USD 9.47 billion globally, with Europe holding over 31 % share and China, the U.S., and France among top producers . The Cannabis and Hemp market exhibits segmentation by end‑use: pharmaceutical, cosmetics, food & beverages, textiles, and advanced industrial applications.

Cannabis and Hemp Market Trends

The Cannabis and Hemp market shows clear geographic trends. North America remains the dominant region, especially the United States and Canada, due to legalisation for both medicinal and adult‑use cannabis, coupled with a broad product variety including CBD oils, edibles, and topical applications. Europe is rapidly gaining traction: Germany, Italy and the Netherlands are adopting favourable regulations and expanding consumer demand for CBD, driving Cannabis and Hemp product uptake in wellness sectors . In Asia‑Pacific, Thailand became the first SE Asia country to legalise medical cannabis, paving the way for broader acceptance of Cannabis and Hemp-derived products. Meanwhile the Middle East & Africa market is nascent but accelerating as countries such as South Africa begin regulatory reforms.

Industrial hemp usage is trending upward: applications in sustainable packaging, bio‑composites and textiles are expanding, with the industrial hemp market estimated at around USD 11.03 billion in 2024. Hemp also accounts for over 78 % of biomass revenue within cannabis cultivation segments as of 2024 . The Cannabis and Hemp market is also influenced by climate‑smart farming practices and indoor cultivation technologies enhancing yield consistency. E‑commerce distribution is growing fast in the wake of regulatory shifts and COVID‑era consumer behavior, further boosting Cannabis and Hemp product accessibility and market penetration.

Cannabis and Hemp Market Dynamics

The Cannabis and Hemp market dynamics reflect a balance between regulatory evolution, consumer preferences, and industrial development. Regulatory dynamics: shifting legal frameworks across regions are enabling cultivation licensing, product approval, and broader distribution channels. Consumer demand: health and wellness trends are increasing uptake of CBD and hemp‑based dietary supplements, while medical cannabis treatment options continue expanding. Industrial supply chain dynamics: global Cannabis and Hemp production involves cultivation, processing, extraction and formulation, with key players optimising vertical integration. Competitive intensity: leading firms such as Curaleaf, Canopy Growth, Ecofibre and others drive product innovation in both Cannabis and Hemp categories. Market segmentation across end‑use sectors (medical, recreational, industrial) and distribution channels (retail dispensaries, online, pharmacies) shapes how Cannabis and Hemp companies compete and grow their footprints.

OPPORTUNITY

"Growth in personalized medicines and diversified formats"

The Cannabis and Hemp market is evolving with tailored cannabinoid therapies and innovative product formulations. Hemp-derived CBD and low-THC extracts are being explored for disease-specific applications including seizure disorders, PTSD, chronic inflammation, and anxiety. Clinical research into minor cannabinoids like CBN and CBG is expanding, offering product diversification beyond traditional THC/CBD. Consumer interest in customized formulations—edibles, nanoemulsified beverages, transdermal patches—is accelerating, especially in the U.S. and Europe. More than 50% of new cannabis product launches in 2023 were personalized or microdosed. The wellness sector offers further opportunity: CBD-infused skin care, sleep aids, and adaptogenic hemp blends are forecast to drive major uptake. Hemp-based building materials and sustainable textiles also present growth potential, especially as more than 30% of global hemp fiber production is used in biocomposites and construction materials. Asia-Pacific nations like Thailand and India are beginning to liberalize hemp cultivation laws, offering scalable low-cost production zones. These developments create lucrative, innovation-friendly spaces in the Cannabis and Hemp market.

DRIVERS

"Rising demand for pharmaceuticals and wellness products "

The Cannabis and Hemp market is being propelled by increased adoption of cannabinoid-based medical treatments and wellness-focused hemp formulations. Over 35 U.S. states now allow some form of medical cannabis use, and Europe is rapidly adopting CBD therapies for conditions such as epilepsy, arthritis, anxiety, and multiple sclerosis. More than 440,000 full-time jobs have been created by the U.S. cannabis sector as of 2024, reflecting rising product demand and sector expansion. Hemp-derived cannabinoids, particularly CBD, are increasingly incorporated into over-the-counter supplements and functional foods. Hemp-based personal care products, including creams, balms, and oils, are experiencing strong uptake in wellness channels. In beverages, CBD-infused drinks are the only subsegment showing growth, with sales increasing by over 50% in 2023. The broadening of application—from clinical medicine to lifestyle wellness—is driving significant market growth for both Cannabis and Hemp.

Market Restraints

"Regulatory fragmentation and inconsistent enforcement :"

One of the key restraints in the Cannabis and Hemp market is the complex and inconsistent legal framework that varies across jurisdictions. In the U.S., some states allow recreational cannabis, others only medical, and several prohibit hemp-derived THC altogether. For instance, California’s proposed ban on hemp-THC beverages in 2025 could eliminate over 18,000 jobs and reduce industry output by more than 25% within a year. In Texas, proposed laws threaten nearly 8,000 licensed hemp businesses, demonstrating the volatility of the legal environment. Furthermore, banking limitations and excessive compliance costs strain operations for small to medium-sized cannabis companies. Inconsistent labeling laws and testing standards make cross-border trade complex, even within national borders. Export restrictions, especially for hemp-based products, hinder international expansion. These regulatory and logistical constraints collectively slow the pace of investment and product scaling in both the Cannabis and Hemp sectors.

Market Challenges

"Rising production costs and infrastructure limitations :"

The Cannabis and Hemp industry faces cost pressures tied to energy-intensive cultivation, equipment depreciation, and limited access to efficient processing technologies. Indoor cultivation requires climate control, water filtration, and artificial lighting—raising electricity costs by as much as 40% compared to outdoor grows. In the U.S., wholesale cannabis prices have experienced swings of 21% quarter-over-quarter due to overproduction and low retail margins. Hemp fiber processing infrastructure remains underdeveloped in many markets, especially in Asia and Africa, limiting scale. Compliance costs related to testing, packaging, and state-by-state licensing compound financial strain—especially for small businesses. In 2024, over 70% of small hemp processors in Texas and California reported regulatory burdens as their top barrier to growth. Additionally, lack of standardized global trade protocols for cannabinoid-rich Hemp products inhibits international scaling. Fragmented testing standards and inadequate transport systems restrict supply chain efficiency. These challenges contribute to production bottlenecks, pricing instability, and investor hesitancy within the Cannabis and Hemp market.

Segmentation Analysis

The Cannabis and Hemp market is segmented by product type, compound, and application. By type, the categories include flowers, concentrates, edibles, beverages, topicals, tinctures, and others. Application segments include medicinal, recreational (adult‑use), industrial (hemp fibre, seeds, bio‑materials) and wellness/nutraceutical formats . Consumer demand varies: medicinal users prefer extracts and tinctures, while recreational users lean toward flower and edibles. Industrial hemp is used for textiles, insulation, bioplastics, animal bedding and construction materials, supporting Cannabis and Hemp stuffing in sustainable applications. This segmentation helps market players tailor strategies, invest in processing—for instance extraction facilities versus fibre decortication—and position products for specific channels like dispensaries, industrial buyers, pharmacies or online platforms.

By Type

• Flowers – The flower segment dominates in both medicinal and recreational Cannabis and Hemp, especially high‑THC cannabis consumed through inhalation. Prices vary significantly: e.g. New Jersey retail flower can reach $2,598 per pound, while Oregon saw a steep 23 % price drop in one season due to oversupply . Flower volume remains central to dispensary sales and consumer uptake.

• Concentrates – Concentrates include oils, tinctures, waxes and extracts derived from Cannabis and Hemp plant material. The extract market was valued at USD 3.5 billion in 2022 in global terms . Demand for concentrates is rising in therapeutic segments treating chronic ailments such as anxiety, cancer‑related pain and Alzheimer’s.

• Others – This covers edibles, beverages, topicals, capsules and tinctures in both Cannabis and Hemp markets. Hemp‑derived THC beverages have captured niche consumer demand, with U.S. cannabis drink sales projected to exceed $1 billion in 2025 and reach over $4 billion by 2028 . These formats support diversification and innovation in distribution channels outside conventional flower and concentrate markets.

By Application

• Medicinal – The medicinal Cannabis and Hemp market features doctor‑prescribed CBD and THC therapies, tinctures, oils and capsules tailored for conditions like glaucoma, arthritis, nausea and epilepsy. Cannabis extract sales alone exceeded USD 3.5 billion globally in 2022 .

• Recreational – Consumer preference for inhalation flower, edibles and beverages under adult‑use legalization drives recreational Cannabis and Hemp adoption in markets such as Canada, U.S. states and parts of Europe. Sales of hemp‑THC drinks are beginning to cannibalize alcohol markets, capturing up to 15 % of retail shelf space in some stores.

• Industrial – Hemp used as fibre, hurd, seeds and oil supports industrial sectors: textiles, bio‑plastics, construction (hemp‑crete), animal bedding and food ingredients. For instance, Europe leads in hemp fibre production, and hemp lime construction offers energy‑efficient insulation solutions .

• Others – Other applications include wellness and nutraceutical products, cosmetics, and essential oils. Natural hemp essential oil costs up to $50 per millilitre and is used in perfumes and botanical beverages.

Cannabis and Hemp Market Regional Outlook

The Cannabis and Hemp market exhibits distinct regional variations. North America, particularly the U.S. and Canada, leads due to legalisation of medical and adult‑use cannabis, robust dispensary networks, and alcohol‑grade hemp‑THC drinks penetrating retail channels. Regulatory risks persist: proposed permanent bans in California and restrictive laws in Texas threaten local hemp and THC beverage markets . Europe is expanding rapidly. Germany, Netherlands, and Italy are enabling broader CBD and hemp flower channels; Italy alone supports over 2,000 light‑cannabis shops and generated roughly €150 million in hemp flower sales via over 1,000 stores by 2018. Hemp fibre and construction materials usage is rising across EU nations like France and Italy and commands sizeable industrial uptake. Asia‑Pacific and other emerging regions – Thailand has pioneered medical cannabis legalisation in Southeast Asia. Other markets in the Middle East & Africa remain nascent but show gradual regulatory shifts, offering long‑term growth avenues for both Cannabis and Hemp segments.

North America

The Cannabis and Hemp market in North America leads globally. In 2024, the legal cannabis market in North America reached USD 44.83 billion, with U.S. adult‑use and medical cannabis sales totaling USD 31.4 billion in 2024—an increase of USD 2.6 billion year‑on‑year. Cannabidiol‑infused beverages in the U.S. generated USD 5.3 billion in 2021 and have since grown into a mainstream segment with shelf‑share reaching 15 percent in multiple state retailers. Hemp‑derived THC drinks have now exceeded USD 1 billion in the U.S. in 2025, already driving shifts from traditional alcohol categories. North American Cannabis and Hemp cultivation dominates, with heavy investment in vertical integration across cultivation, extraction and retail distribution. Banking limitations remain a hurdle; still, over 440,000 full‑time jobs are supported by the U.S. cannabis sector.

Europe

In Europe, the Cannabis and Hemp market is quickly emerging. Industrial hemp accounted for over 31 percent of the global hemp market value in 2024, placing Europe at the forefront of hemp fibre and seed processing. Italy hosts over 2,000 light‑cannabis shops, generating an early market value of roughly €150 million via more than 1,000 outlets by 2018—hemp flower retail models continue expanding across nations like Germany, the Netherlands and France. CBD wellness uptake is rising, with health‑oriented consumers driving demand for Cannabis and Hemp‑based nutraceuticals and personal care products. Regulatory improvements in medical cannabis frameworks across countries like Germany and Italy further enable market diversification into both medicinal and industrial end‑uses under the Cannabis and Hemp stuffing umbrella.

Asia‑Pacific

The Asia‑Pacific region is a fast‑evolving hub for the Cannabis and Hemp market. Industrial hemp was valued at USD 2,347.45 million in 2023 in Asia‑Pacific, led by major producers such as China, India, and Thailand. Thailand’s legalization of medical cannabis spurred a USD 1 billion cannabis‑related industry, launching approximately 11,000 dispensaries before regulatory rollback measures tightened rules—highlighting volatility in Cannabis and Hemp policy dynamics. China remains the world’s largest exporter of hemp paper, textiles, and bio‑composites, reinforcing Asia‑Pacific’s dominance in Cannabis and Hemp supply chains and stuffing applications for industrial fibre and bioproducts.

Middle East & Africa

Middle East & Africa represent early but promising frontiers in the Cannabis and Hemp market. Although nascent, countries like South Africa are introducing regulatory reforms allowing medicinal cannabis frameworks. Interest is growing in Cannabis and Hemp‑based wellness and industrial products. Regional stakeholders are focusing on hemp fibre and seed cultivation for sustainable textile and nutraceutical applications, aligning with emerging socio‑economic priorities in the region. While comprehensive figures remain scarce, legislative momentum suggests potential for Cannabis and Hemp cultivation zones, especially in South Africa and parts of North Africa, as demand grows from both local and export markets.

LIST OF KEY Cannabis and Hemp Market COMPANIES PROFILED

Investment Analysis and Opportunities

Investor interest in the Cannabis and Hemp market intensified in 2023 and 2024 as major operators diversified product lines and sought new revenue streams. For example, Green Thumb Industries, Curaleaf Holdings, and Trulieve introduced hemp‑derived THC beverages in early 2025, signaling investor confidence in low‑THC formats that skirt traditional cannabis regulation. Legal cannabis in the U.S. is projected to reach approximately USD 45 billion in 2025, supporting over 440,000 full‑time jobs. Investment flows have shifted toward integrated cultivation‑to‑retail verticals, AI‐supported cultivation firms (e.g. UK Glass Pharms deploying AI monitoring in 2024), and sustainable hemp fibre companies in Australia’s Ecofibre expanding operations in the U.S. and Australia.

Private equity and venture capital have targeted hemp fibre startups in South Australia (e.g. Vircura/South Fibre pilot plant opening in 2023) and hemp‑based construction integrations like hempcrete panels gaining traction in Europe. In North America, over 945 new cannabis manufacturing licenses were issued in 2024—up 27% from 2023—boosting on‑path capital deployment in production infrastructure . Strategic opportunities include funding scalable hemp‑derived wellness brands and beverage franchises via platforms like Edibles.com launched by Edible Brands in Texas in 2025. Additionally, potential federal regulatory reforms in the U.S. including cannabis rescheduling and farm bill updates could unlock further institutional investment. Despite complexities, the most attractive ventures are targeting regulated hemp‑THC beverages, industrial hemp fibre for textiles and construction, and AI‑enabled cultivation farms—each backed by tangible deployment metrics across 2023–2025.

New Products Development

Product innovation in the Cannabis and Hemp market accelerated during 2023 and 2024, with leading manufacturers launching new formats and technologies. Trulieve’s Onward line released hemp‑derived THC beverages with flavors like sea salt margarita, peach bellini and blueberry mojito in early 2025 via online distribution to 36 states. Curaleaf’s Select THC beverages and Green Thumb’s investments in the Señorita brand expanded shelf presence of low‑THC drinks in liquor retailers across multiple U.S. markets. Edible Brands launched Edibles.com in 2025 offering hemp‑based seltzers, chews and low‑THC gummies in Georgia, Florida and Texas, targeting legal markets with user‑friendly e‑commerce platforms .

In the industrial hemp space, ACS Laboratory highlighted CBD‑infused beverages posted over 50% sales growth in 2023, making drinks the only sub‑category to grow amid broader CBD declines. Hemp fibre applications saw expansion into durable textiles, pulp and paper blends, and biocomposite building blocks—including hemp‑cement, MDF and insulation materials—in multiple global regions . Extraction technology advanced with sub‑zero and filtration methods enabling CBD potency increases up to 40× over older protocols, supporting new wellness and skincare formulations.

Meanwhile in the UK, Glass Pharms deployed AI‑assisted automated greenhouses in 2024, enabling carbon‑neutral medicinal cannabis cultivation and delivering first patient shipments in June 2024. Ecofibre expanded its hemp‑derived nutraceutical, cannabinoid, food and textile products across U.S. and Australian markets in 2023–2024, integrating vertically and scaling clinical‑grade CBD formulations . These product developments reflect strong focus on diversified formats—including beverages, fibre‑based biotech products, advanced extraction‑derived skincare and wellness offerings—fueled by technological innovation and consumer demand.

Recent Developments by Manufacturers

• Trulieve, Curaleaf Holdings and Green Thumb Industries launched hemp‑derived THC beverages (Select, Onward, Señorita lines) in early 2025, after development through 2024.

• Edible Brands debuted Edibles.com in 2025, offering hemp‑based edibles, seltzers and gummies in southern U.S. states, built on 2023 product pipelines.

• Glass Pharms in the UK began automated AI‑monitored cannabis cultivation in 2024 and shipped their first medical cannabis products to patients in June 2024.

• Ecofibre expanded hemp‑derived CBD, nutraceutical, food and textile product lines across U.S. and Australian markets during 2023–2024.

• Licensing expansion: 945 new cannabis manufacturing licenses issued in the U.S. in 2024, up 27% from 2023, enabling scale‑up at manufacturers leveraging Cannabis and Hemp processes.

REPORT COVERAGE of Cannabis and Hemp Market

This report covers global Cannabis and Hemp industry structure—including segmentation by type (flowers, concentrates, others) and by application (medicinal, recreational, industrial, others), and regional breakdown (North America, Europe, Asia‑Pacific, Middle East & Africa). It profiles leading companies and region‑wise adoption trends. It examines regulatory frameworks, manufacturing licensing dynamics, and supply chain integrations. Sections outline investment landscapes, new product pipelines, technological innovations in extraction and cultivation, and structural challenges such as compliance costs and banking restrictions. The report reviews case studies from Ecofibre, Trulieve, Curaleaf, Glass Pharms and Edible Brands, showing how innovation is transforming beverage, wellness, industrial‑fibre and cannabis‑derived product lines. It includes data on manufacturing licence expansion (945 new in 2024), CBD beverage category growth (>50%), and hemp‑THC beverage shelf share displacement in conventional alcohol categories. Coverage extends to emerging markets in Asia‑Pacific and regulatory shifts influencing regional dynamics.